NZ249509A - 6-benzyl triazolopyrimidine derivatives and pharmaceutical compositions - Google Patents

6-benzyl triazolopyrimidine derivatives and pharmaceutical compositions

Info

Publication number
NZ249509A
NZ249509A NZ249509A NZ24950993A NZ249509A NZ 249509 A NZ249509 A NZ 249509A NZ 249509 A NZ249509 A NZ 249509A NZ 24950993 A NZ24950993 A NZ 24950993A NZ 249509 A NZ249509 A NZ 249509A
Authority
NZ
New Zealand
Prior art keywords
formula
radical
propyl
group
carbon atoms
Prior art date
Application number
NZ249509A
Other languages
English (en)
Inventor
Nicole Bru-Magniez
Timur Gungor
Jean-Marie Teulon
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9202109A external-priority patent/FR2687676B1/fr
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of NZ249509A publication Critical patent/NZ249509A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ249509A 1992-02-24 1993-02-18 6-benzyl triazolopyrimidine derivatives and pharmaceutical compositions NZ249509A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9202109A FR2687676B1 (fr) 1992-02-24 1992-02-24 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR9205417A FR2687677B1 (fr) 1992-02-24 1992-04-30 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
NZ249509A true NZ249509A (en) 1996-06-25

Family

ID=26229283

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ249509A NZ249509A (en) 1992-02-24 1993-02-18 6-benzyl triazolopyrimidine derivatives and pharmaceutical compositions
NZ249508A NZ249508A (en) 1992-02-24 1993-02-18 6-benzylpyrazolopyrimidine derivatives and medicaments

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ249508A NZ249508A (en) 1992-02-24 1993-02-18 6-benzylpyrazolopyrimidine derivatives and medicaments

Country Status (19)

Country Link
EP (2) EP0628045A1 (enrdf_load_html_response)
JP (2) JPH07504177A (enrdf_load_html_response)
KR (2) KR100272922B1 (enrdf_load_html_response)
AT (1) ATE179979T1 (enrdf_load_html_response)
AU (2) AU668544B2 (enrdf_load_html_response)
CA (2) CA2128871A1 (enrdf_load_html_response)
CZ (2) CZ204594A3 (enrdf_load_html_response)
DE (1) DE69324910T2 (enrdf_load_html_response)
EE (2) EE03046B1 (enrdf_load_html_response)
ES (1) ES2133390T3 (enrdf_load_html_response)
FI (2) FI943808A7 (enrdf_load_html_response)
FR (1) FR2687677B1 (enrdf_load_html_response)
HU (2) HU220392B (enrdf_load_html_response)
MD (2) MD553G2 (enrdf_load_html_response)
NZ (2) NZ249509A (enrdf_load_html_response)
RU (1) RU2116308C1 (enrdf_load_html_response)
SK (2) SK280343B6 (enrdf_load_html_response)
TW (2) TW222275B (enrdf_load_html_response)
WO (2) WO1993017023A1 (enrdf_load_html_response)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
TWI334868B (en) * 2003-06-03 2010-12-21 Nippon Kayaku Kk [1,2,4] triazoro [1,5-a] pyrimidine-2-ylurea derivative and use thereof
EP1876899A2 (de) * 2005-04-25 2008-01-16 Basf Aktiengesellschaft Verwendung von 5-alkyl-6-phenylalkyl-7-amino-azolopyrimidinen, neue azolopyrimidine, verfahren zu ihrer herstellung und sie enthaltende mittel
WO2008003753A1 (en) * 2006-07-07 2008-01-10 Biovitrum Ab (Publ) Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity
DE102006039255A1 (de) * 2006-08-17 2008-02-21 Bayer Cropscience Ag Insektizide heterocyclische Carbonsäurederivate
WO2010087515A1 (en) * 2009-01-30 2010-08-05 Takeda Pharmaceutical Company Limited Fused ring compound and use thereof
EP2621928A1 (en) 2010-09-27 2013-08-07 Proximagen Limited 7-hydroxy-pyrazolo[1,5-a]pyrimidine compounds and their use as ccr2 receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
CA2079344A1 (en) * 1990-03-30 1991-10-01 Eric E. Allen Substituted pyrimidines, pyrimidinones and pyridopyrimidines
FR2678618B1 (fr) * 1991-07-05 1993-11-05 Upsa Laboratoires Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
JPH07504178A (ja) 1995-05-11
FI943808L (fi) 1994-10-24
CZ204494A3 (en) 1994-12-15
FR2687677B1 (fr) 1996-10-11
EE03045B1 (et) 1997-10-15
MD553G2 (ro) 1996-12-31
HU220392B (hu) 2002-01-28
HUT70953A (en) 1995-11-28
CA2128876A1 (en) 1993-09-02
MD554F1 (en) 1996-05-31
AU3635793A (en) 1993-09-13
FI943807A7 (fi) 1994-10-24
HU9402429D0 (en) 1994-10-28
DE69324910T2 (de) 1999-10-21
HUT70949A (en) 1995-11-28
KR100272922B1 (ko) 2001-02-01
KR950700303A (ko) 1995-01-16
MD554G2 (ro) 1997-01-31
AU3635893A (en) 1993-09-13
ES2133390T3 (es) 1999-09-16
EP0628046A1 (fr) 1994-12-14
CZ204594A3 (en) 1994-12-15
FI943808A7 (fi) 1994-10-24
SK99794A3 (en) 1995-04-12
EP0628045A1 (fr) 1994-12-14
TW222275B (enrdf_load_html_response) 1994-04-11
ATE179979T1 (de) 1999-05-15
NZ249508A (en) 1996-07-26
FI943807A0 (fi) 1994-08-19
HU9402430D0 (en) 1994-10-28
AU668139B2 (en) 1996-04-26
FI943808A0 (fi) 1994-08-19
CZ282075B6 (cs) 1997-05-14
KR950700302A (ko) 1995-01-16
RU94040854A (ru) 1996-08-10
AU668544B2 (en) 1996-05-09
EE03046B1 (et) 1997-10-15
RU2116308C1 (ru) 1998-07-27
JP3372040B2 (ja) 2003-01-27
SK99894A3 (en) 1995-04-12
CA2128876C (en) 2004-02-03
CA2128871A1 (en) 1993-09-02
JPH07504177A (ja) 1995-05-11
FR2687677A1 (fr) 1993-08-27
TW221438B (enrdf_load_html_response) 1994-03-01
EP0628046B1 (fr) 1999-05-12
WO1993017023A1 (fr) 1993-09-02
MD553F1 (en) 1996-05-31
DE69324910D1 (de) 1999-06-17
FI943807L (fi) 1994-10-24
SK280343B6 (sk) 1999-12-10
WO1993017024A1 (fr) 1993-09-02

Similar Documents

Publication Publication Date Title
AU2005299421B2 (en) Compounds and compositions as inhibitors of Cannabinoid Receptor 1 activity
US5231094A (en) Triazolopyrimidines which are angiotensin II receptor antagonists and pharmaceutical compositions in which they are present
DE602005004287T2 (de) Pyrrazolopyrimidinderivate
JP3140566B2 (ja) アンギオテンシンｉｉリセプタ拮抗剤である新規なトリアゾロピリミジン誘導体、その製造方法、およびそれを含有する医薬組成物
HUP0203477A2 (hu) Alkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállítási eljárásaik
SK13752003A3 (en) Substituted pyrazinones, pyridines and pyrimidines as ligands of factor releasing corticotropine
JPH06211846A (ja) ベンゾフラン誘導体
US5387747A (en) Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
NZ249509A (en) 6-benzyl triazolopyrimidine derivatives and pharmaceutical compositions
US5389632A (en) Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
JPS60246387A (ja) ジヒドロイミダゾ〔１，２−ａ〕ピリミジン誘導体
Farghaly et al. Synthesis of imidazo [1, 2-c] pyrazolo [4, 3-e] pyrimidines derived from indole and related heterocycles
Kepe et al. OXAZOLONE AS A SYNTHON FOR THE SYNTHESIS OF VARIOUS PYRAZOLES AND FUSED PYRIMIDINES'
El-Kashef et al. Synthesis of 3-azaharman and other new azacarbolines of the pyridazino [4, 5-b] indole type
TW202339720A (zh) 作為trpa1抑制劑之噠嗪酮化合物
Zupančič et al. Transformations of Dialkyl Acetone-1, 3-dicarboxylates via Their Dimethylaminomethylidene Derivatives Into 1-substituted 4-ethoxycarbonyl-5-(ethoxycarbonylmethyl) pyrazoles, 7-amino-2-ethoxycarbonyl-1H, 2H-pyrazolo [2, 3-c] pyrimidin-5-one, 4-hydroxypyridin-2 (1H)-ones and 6-substituted 3-benzoylamino-2, 5-dioxo-5, 6-dihydro-2H-pyrano [3, 2-c] pyridine-8-carboxylates
JPH01228991A (ja) 気管支拡張剤としての置換１，２，４−トリアゾロ〔１，５−ａ〕トリアジン
JP2006342162A (ja) ３−アミノ−４，５二置換ピラゾール誘導体の製造

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired